Miguel R.
- Country
- Spain
- Department
- Urology
Research Overview
- Evaluation of Preoperative Electromotive Mitomycin-C Administration in Non-Muscle Invasive Bladder Carcinoma: A Randomized Controlled Trial
- Phase 3 Randomized, Double-blind, Placebo-controlled Study of Apalutamide and Androgen Deprivation Therapy in High-risk Localized or Locally Advanced Prostate Cancer
- Phase 3 Randomized Trial of Intravesical Erdafitinib Delivery System vs. Single-Agent Chemotherapy in FGFR+ Intermediate-Risk Non-Muscle Invasive Bladder Cancer
Data & Insights
Has run more than one trial at 68 of 239 partner sites.
Specializations
Urological Oncology
This investigator specializes in the treatment of non-muscle invasive bladder tumors, with particular focus on innovative therapeutic approaches in urological cancer management.
- Bladder Cancer Treatment
- Non-invasive Therapeutic Techniques
- Urothelial Carcinoma Management
The investigator explores advanced drug delivery methods in bladder cancer treatment, including electromotive drug administration techniques.
Drug Delivery Innovation
The research focuses on optimizing therapeutic delivery systems, particularly investigating electromotive drug administration (EMDA) as an alternative to conventional treatment methods.
- Novel Drug Administration Techniques
- Preoperative Treatment Strategies
- Targeted Drug Delivery Systems
Special attention is given to improving drug absorption and distribution in bladder tissue through innovative delivery mechanisms.
Clinical Outcomes
The investigator studies the effectiveness of various treatment approaches in urothelial carcinoma, with particular emphasis on disease recurrence and progression patterns.
- Treatment Efficacy Assessment
- Disease Progression Monitoring
- Long-term Outcome Analysis
Research encompasses comparative analysis of different therapeutic interventions in bladder cancer management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.